Lab-developed tests look likely to be removed from FDA oversight. That has to change, writes Walter G. Johnson.

A CAR-T trial is one of several efforts that suggest there’s hope of treating the “worst imaginable childhood brain tumor,” ...

Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...

RFK Jr.'s 'Make America Healthy Again' agenda focuses on overhauling health care and food to combat chronic disease ...

Good morning health tech readers! Today, details about Amazon’s new mental health partner, another digital health company ...

Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.

Today's health news includes understanding Plan B's efficacy for people with higher BMIs, disparities in infant mortality, ...

Measles cases rose 20% worldwide in 2023 compared to the previous year, and vaccination rates still haven't recovered to ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

In choosing Thune, Republicans went with an establishment candidate with close ties to the outgoing and long-time Senate ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...